Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Nicotinic acetylcholine receptors are ligand‐gated ion channels that exogenously bind nicotine. Nicotine produces rewarding effects by interacting with these receptors in the brain's reward system. Unlike other receptors, chronic stimulation by an agonist induces an upregulation of receptor number that is not due to increased gene expression in adults; while upregulation also occurs during development and adolescence there have been some opposing findings regarding a change in corresponding gene expression. These receptors have also been well studied with regard to human genetic associations and, based on evidence suggesting shared genetic liabilities between substance use disorders, numerous studies have pointed to a role for this system in comorbid drug use. This review will focus on upregulation of these receptors in adulthood, adolescence and development, as well as the findings from human genetic association studies which point to different roles for these receptors in risk for initiation and continuation of drug use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523 · cited 3×
“…al. 2012; Chen et al. 2009; Erlich et al. 2010; Haller et al. 2012; Maes et al. 2011; Saccone et al. 2009a,b; Sherva et al. 2010; Spitz et al. 2008; Thorgeirsson et al. 2008; Weiss et al. 2008; Wessel et al. 2010), but more recently the genes for other nAChR subunits have been associated with…”
BackgroundFlores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850 · cited 2×
“…behavior (Baker et al. 2009; Berrettini et al. 2008; Bierut et al. 2007; Chen et al. 2009, 2012a; Furberg et al. 2010; Hartz et al. 2012; Liu et al. 2010; Saccone et al. 2007, 2010a; Sherva et al. 2010; Stevens et al. 2008; Thorgeirsson et al. 2008, 2010; Weiss et al. 2008; Winterer et al. 2010).”
BackgroundGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · cited 2×
“…Marks et al. (1983) chronically infused mice with 5 mg/kg/h nicotine for 8–10 days (mice are less sensitive to the effects of nicotine than rats are (Matta et al. 2007), accounting for the difference in nicotine treatments in these two experiments) and reported an increase in (−)-[3H]nicotine…”
BackgroundFamilial Transmission of Substance Use Disorders
Merikangas, K. R., Stolar, M., Stevens, D. E., Goulet, J., Preisig, M. A., Fenton, B., Zhang, H., O'Malley, S. S., & Rounsaville, B. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.973 · Cited by 783 · cited 2×
“abuse or dependence criteria for more than one legal or illegal drug) is high (Bierut et al. 1998; Kapusta et al. 2007; Kendler et al. 1997; Kessler et al. 1997; Merikangas et al. 1998; Pickens et al. 1995).”
BackgroundKendler, K. S., Jacobson, K. C., Prescott, C. A., & Neale, M. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.687 · Cited by 693 · cited 2×
“…genetic factors specific to each substance have been identified, research has indicated that a common genetic factor underlies much of the variation in SUDs in adults (Agrawal et al. 2004; Kendler et al. 2003; Palmer et al. 2012, 2015; True et al. 1999a,b; Tsuang et al. 2001; Xian et al. 2008).”
BackgroundSequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
The ENGAGE Consortium, Thorgeirsson, T. E., Gudbjartsson, D. F., Surakka, I., Vink, J. M., Amin, N., Geller, F., Sulem, P., Rafnar, T., Esko, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.573 · Cited by 689 · cited 14×
“This cluster of genes has been the most consistently replicated association with cigarettes per day (CPD) (Berrettini et al. 2008; Cannon et al. 2014; Caporaso et al. 2009; Furberg et al. 2010; Gabrielsen et al. 2013; Liu et al. 2010; Saccone et al. 2010a; Sarginson et al. 2011; Sorice et al. 2011; Stevens et al. 2008…”
BackgroundResultInfluentialVariants in Nicotinic Receptors and Risk for Nicotine Dependence
Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Saccone, N. L., Saccone, S. F., Bertelsen, S., Fox, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111711 · Cited by 648 · cited 1×
“…2010a; Sarginson et al. 2011; Sorice et al. 2011; Stevens et al. 2008; Thorgeirsson et al. 2010) and nicotine dependence (ND) (Baker et al. 2009; Bierut et al. 2007, 2008; Broms et al. 2012; Chen et al. 2009; Erlich et al. 2010; Haller et al. 2012; Maes et al. 2011; Saccone et al. 2009a,b;…”
BackgroundSelf-citationNovel genes identified in a high-density genome wide association study for nicotine dependence
Bierut, L. J., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., Swan, G. E., Rutter, J., Bertelsen, S., Fox, L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl441 · Cited by 622
Meta-analysis and imputation refines the association of 15q25 with smoking quantity
The Wellcome Trust Case Control Consortium, Liu, J. Z., Tozzi, F., Waterworth, D. M., Pillai, S. G., Muglia, P., Middleton, L., Berrettini, W., Knouff, C. W., Yuan, X., et al. (2010) · Nature Genetics · doi:10.1038/ng.572 · Cited by 614 · cited 10×
“This cluster of genes has been the most consistently replicated association with cigarettes per day (CPD) (Berrettini et al. 2008; Cannon et al. 2014; Caporaso et al. 2009; Furberg et al. 2010; Gabrielsen et al. 2013; Liu et al. 2010; Saccone et al. 2010a; Sarginson et al. 2011; Sorice et al. 2011; Stevens et al. 2008…”
BackgroundInfluentialPharmacology of Nicotine: Addiction and Therapeutics
Benowitz, N. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003121 · Cited by 589 · cited 1×
“This is particularly interesting because smokers have an average serum concentration of 100–200 nM nicotine after smoking (Benowitz 1996; Henningfield et al. 1993), suggesting that nAChR upregulation could occur in smokers in between, as well as during, periods of smoking.”
BackgroundThe dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Luetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558
Iacono, W. G., Malone, S. M., & McGue, M. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141157 · Cited by 554
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479 · cited 5×
“However, the nicotine doses were slightly different than those used in the first studies showing upregulation; 2 mg/kg/h vs. 5 mg/kg/h nicotine (Marks et al. 1983) in mice and 6 mg/kg/day vs. 4 mg/kg/day (Schwartz & Kellar 1983) in rats.”
BackgroundMethodInfluentialStructural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking
Berrettini, W., Yuan, X., Tozzi, F., Song, K., Francks, C., Chilcoat, H., Waterworth, D., Muglia, P., & Mooser, V (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002154 · Cited by 465
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453 · cited 1×
“Nicotine is able to cross the blood–brain barrier and bind neuronal nAChRs in the brain (Clarke 1987), producing rewarding effects by interacting with nAChRs in the brain’s reward system (Changeux 2010).”
BackgroundKendler, K. S., Davis, C. G., & Kessler, R. C. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.6.541 · Cited by 412 · cited 2×
“abuse or dependence criteria for more than one legal or illegal drug) is high (Bierut et al. 1998; Kapusta et al. 2007; Kendler et al. 1997; Kessler et al. 1997; Merikangas et al. 1998; Pickens et al. 1995).”
BackgroundLe Novère, N., Corringer, P., & Changeux, J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10153 · Cited by 411
Effect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396
Saccone, N. L., Culverhouse, R. C., Schwantes-An, T.-H., Cannon, D. S., Chen, X., Cichon, S., Giegling, I., Han, S., Han, Y., Keskitalo-Vuokko, K., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001053 · Cited by 395 · cited 6×
“In addition, evidence for association between common variants in other CHRN genes (CHRND-G, CHRNB1, CHRNA10, CHRNA4 and CHRNB2) and CPD and ND have been reported, although less replicated (Chen et al. 2013; Han et al. 2011; Kamens et al. 2013; Li et al. 2005; Saccone et al. 2009a, 2010b).”
BackgroundInfluentialSelf-citationPeng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Weiss, R. B., Baker, T. B., Cannon, D. S., von Niederhausern, A., Dunn, D. M., Matsunami, N., Singh, N. A., Baird, L., Coon, H., McMahon, W. M., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000125 · Cited by 271
Nicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261 · cited 6×
“Similar to some of the work described above, several studies have proposed nAChR upregulation is caused by increased subunit maturation and receptor assembly in the ER (Harkness & Millar 2002; Nashmi et al. 2003; Sallette et al. 2005).”
BackgroundResultInfluentialEvidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats
Adriani, W., Spijker, S., Deroche-Gamonet, V., Laviola, G., Le Moal, M., Smit, A. B., & Piazza, P. V. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04712.2003 · Cited by 257 · cited 2×
“04 mg/kg for 1 h) during adolescence (Adriani et al. 2003).”
BackgroundInfluentialTrauth, J. A., Seidler, F. J., McCook, E. C., & Slotkin, T. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01994-0 · Cited by 230 · cited 2×
“2008), particularly in the midbrain, hippocampus and cortex (Abreu-Villaca et al. 2003; Trauth et al. 1999).”
BackgroundWang, J. C., Grucza, R., Cruchaga, C., Hinrichs, A. L., Bertelsen, S., Budde, J. P., Fox, L., Goldstein, E., Reyes, O., Saccone, N., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.42 · Cited by 226 · cited 4×
“This signal has also been associated with alcohol dependence (AD) (Wang et al. 2009), cocaine dependence (CD) (Grucza et al.”
BackgroundInfluentialSaccone, N. L., Saccone, S. F., Hinrichs, A. L., Stitzel, J. A., Duan, W., Pergadia, M. L., Agrawal, A., Breslau, N., Grucza, R. A., Hatsukami, D., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30828 · Cited by 215
Self-citationMaternal tobacco smoking, nicotine replacement and neurobehavioural development
Pauly, J. R., & Slotkin, T. A. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00852.x · Cited by 214
Liability to substance use disorders: 1. Common mechanisms and manifestations
Vanyukov, M. M., Tarter, R. E., Kirisci, L., Kirillova, G. P., Maher, B. S., & Clark, D. B. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.002 · Cited by 205 · cited 9×
“Converging evidence from twin studies highlights the importance of genetic factors on SUDs with estimates of heritability ranging from 0.30 to 0.70 (Agrawal & Lynskey 2008).”
BackgroundInfluentialChronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201
Nicotinic Receptor Gene Variants Influence Susceptibility to Heavy Smoking
Stevens, V. L., Bierut, L. J., Talbot, J. T., Wang, J. C., Sun, J., Hinrichs, A. L., Thun, M. J., Goate, A., & Calle, E. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0585 · Cited by 190
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188 · cited 5×
“Similar to some of the work described above, several studies have proposed nAChR upregulation is caused by increased subunit maturation and receptor assembly in the ER (Harkness & Millar 2002; Nashmi et al. 2003; Sallette et al. 2005).”
BackgroundResultInfluentialWang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187
Schlaepfer, I. R., Hoft, N. R., Collins, A. C., Corley, R. P., Hewitt, J. K., Hopfer, C. J., Lessem, J. M., McQueen, M. B., Rhee, S. H., & Ehringer, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.024 · Cited by 186 · cited 4×
“CHRNA5-A3-B4 has been associated with AD (Chen et al. 2009; Sherva et al. 2010; Wang et al. 2009), alcohol use (Broms et al. 2012; Hallfors et al. 2013), age of initiation of alcohol use (Schlaepfer et al. 2008) and level of response to alcohol (Joslyn et al. 2008).”
BackgroundResultInfluentialSelf-citationDefining nicotine dependence for genetic research: evidence from Australian twins
LESSOV, C. N., MARTIN, N. G., STATHAM, D. J., TODOROV, A. A., SLUTSKE, W. S., BUCHOLZ, K. K., HEATH, A. C., & MADDEN, P. A. F. (2004) · Psychological Medicine · doi:10.1017/s0033291703001582 · Cited by 185 · cited 2×
“…studies have estimated that ND and CPD are roughly 56–72% and 51–61% heritable in men and women, respectively (Broms et al. 2006; Kendler et al. 1999; Lessov et al. 2004; True et al. 1999b; Vink et al. 2004); however, the most well-replicated of these associations accounts for a very small…”
BackgroundSlotkin, T. A., Orband-Miller, L., & Queen, K. L. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39058-0 · Cited by 183
Pauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20464-5 · Cited by 152
A Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence
Grucza, R. A., Wang, J. C., Stitzel, J. A., Hinrichs, A. L., Saccone, S. F., Saccone, N. L., Bucholz, K. K., Cloninger, C. R., Neuman, R. J., Budde, J. P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.018 · Cited by 152
Self-citationAbreu-Villaça, Y., Seidler, F. J., Qiao, D., Tate, C. A., Cousins, M. M., Thillai, I., & Slotkin, T. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300221 · Cited by 151
Levin, E. D., Lawrence, S. S., Petro, A., Horton, K., Rezvani, A. H., Seidler, F. J., & Slotkin, T. A. (2007) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.02.002 · Cited by 147 · cited 2×
“2003), and is more robust, showing increased binding in the midbrain and striatum compared to adults (Levin et al. 2007).”
BackgroundInfluentialSherva, R., Wilhelmsen, K., Pomerleau, C. S., Chasse, S. A., Rice, J. P., Snedecor, S. M., Bierut, L. J., Neuman, R. J., & Pomerleau, O. F. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02279.x · Cited by 143
Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D., Bergen, A. W., Swan, G. E., Tyndale, R. F., Benowitz, N. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn181 · Cited by 136
Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37658-x · Cited by 136 · cited 6×
“…smokers has little effect on muscle nAChRs (Lindstrom 1996), upregulation of ganglionic 𝛼3𝛽4 and 𝛼7 subunits, as well as the muscle type nAChR subunits 𝛼1, 𝛽1, 𝛾 and 𝛿, has been observed on the cell surface after a 48 h exposure to nicotine at concentrations as low as 1 μM (Ke et al. 1998).”
BackgroundInfluentialMao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Doura, M. B., Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.056 · Cited by 129
Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity
Rezvani, K., Teng, Y., Shim, D., & De Biasi, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3353-07.2007 · Cited by 113
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · cited 3×
“Consistent with studies that treated adult rats with 3 or 6 mg/kg/day nicotine (Mugnaini et al. 2006; Perry et al. 2007), downregulation of 𝛼6-containing receptors was observed immediately in adolescent rats after discontinuing chronic nicotine treatment of roughly 3 mg/kg/day (Doura et al. 2008).”
BackgroundEffect of maternal nicotine on the development of sites for [3H]nicotine binding in the fetal brain
Hagino, N., & Lee, J. W. (1985) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(85)90046-2 · Cited by 98 · cited 2×
“…studies have found evidence for nAChR (particularly the 𝛼4𝛽2-containing and 𝛼7 receptors) upregulation in rodents exposed to nicotine during prenatal (Hagino & Lee 1985; Navarro et al. 1989; Popke et al. 1997; Slotkin et al. 1987; Tizabi & Perry 2000; Tizabi et al. 1997; van de Kamp & Collins…”
BackgroundMethodInfluentialTemporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study
Mamede, M., Ishizu, K., Ueda, M., Mukai, T., Iida, Y., Kawashima, H., Fukuyama, H., Togashi, K., & Saji, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043471 · Cited by 91 · cited 2×
“Subsequent studies provided evidence that when nicotine exposure is ceased, decreased binding of (−)-[3H]nicotine occurs after 7–10 days in mice (Marks et al. 1985), 15–20 days in rats (Collins et al. 1990), and between 21 days and 2 months in humans (Breese et al. 1997; Mamede et al. 2007).”
BackgroundCollins, A. C., Romm, E., & Wehner, J. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90222-l · Cited by 79
Darsow, T., Booker, T. K., Piña-Crespo, J. C., & Heinemann, S. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501157200 · Cited by 76 · cited 2×
“This result, however, was not seen when the authors measured intracellular nAChRs (Darsow et al. 2005).”
ResultHarkness, P. C., & Millar, N. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10172.2002 · Cited by 74
Tumkosit, P., Kuryatov, A., Luo, J., & Lindstrom, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027326 · Cited by 73 · cited 4×
“In addition, the 𝛽3 subunit has been shown to co-assemble into a functional receptor composed of 𝛼3𝛽3𝛽4 subunits in oocytes (Groot-Kormelink et al. 1998), and may promote expression and stability of human 𝛼6 subunits in transfected cell lines (Tumkosit et al. 2006).”
BackgroundInfluentialHeath, C. J., King, S. L., Gotti, C., Marks, M. J., & Picciotto, M. R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.130 · Cited by 59 · cited 2×
“Using a mouse model, work by Picciotto and colleagues have demonstrated that the effects of nicotine exposure during development on later behaviors are attributable to the neuropharmacological effects of nicotine itself, not the effect of nicotine on maternal behaviors (Heath et al. 2010a).”
Rezvani, K., Teng, Y., Pan, Y., Dani, J. A., Lindstrom, J., García Gras, E. A., McIntosh, J. M., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4723-08.2009 · Cited by 46
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.105 · Cited by 43 · cited 1×
“Finally, evidence for rare variant associations in both EA and African American samples in the CHRNA5 gene were reported for ND (Olfson et al. 2015).”
BackgroundSelf-citationSlotkin, T. A., Cousins, M. M., & Seidler, F. J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.009 · Cited by 40
Slotkin, T. A., Bodwell, B. E., Ryde, I. T., & Seidler, F. J. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.12.009 · Cited by 36 · cited 1×
“Finally, similar to prenatal exposure, adolescent rat exposure to 6 mg/kg/day nicotine has been shown to alter the activity of the cholinergic system in adulthood (Slotkin et al. 2008).”
BackgroundZhang, X., Gong, Z.-H., Hellström-Lindahl, E., & Nordberg, A. (1995) · Neuroreport · doi:10.1097/00001756-199501000-00022 · Cited by 36
ON THE MECHANISMS OF 14C-NICOTINE DISTRIBUTION IN RAT SUBMAXILLARY GLAND IN VITRO
PUTNEY, J. W., & BORZELLECA, J. F. (1971) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28947-9 · Cited by 22
Cited by
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. (2019) · Nature · doi:10.1038/s41586-019-1075-9 · Cited by 334
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Laviolette, S. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108411 · Cited by 57
Metadata
- Authors
- Melroy‐Greif, W. E., Stitzel, J. A., & Ehringer, M. A.
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2015-12-23
- Volume
- 15
- Issue
- 1
- Pages
- 89-107
- ISSN
- 1601-183X (ISSN-L)
- 1601-1848
- OpenAlex
- W1892246600
- Cited by
- 55
- References
- 67
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.